MEDP Medpace Holdings Inc

Price (delayed)

$175.16

Market cap

$6.3B

P/E Ratio

39.1

Dividend/share

N/A

EPS

$4.48

Enterprise value

$6.08B

Highlights
The EPS is up by 47% YoY and by 10% QoQ
The net income has increased by 45% YoY and by 10% from the previous quarter
The P/E is 20% lower than the 5-year quarterly average of 49.0 but 16% higher than the last 4 quarters average of 33.6
The debt has soared by 122% year-on-year

Key stats

What are the main financial stats of MEDP
Market
Shares outstanding
35.97M
Market cap
$6.3B
Enterprise value
$6.08B
Valuations
Price to earnings (P/E)
39.1
Price to book (P/B)
7.29
Price to sales (P/S)
6.56
EV/EBIT
33.67
EV/EBITDA
28.2
EV/Sales
6.37
Earnings
Revenue
$955.01M
EBIT
$180.63M
EBITDA
$215.71M
Free cash flow
$234.56M
Per share
EPS
$4.48
Free cash flow per share
$6.56
Book value per share
$24.04
Revenue per share
$26.71
TBVPS
$20.8
Balance sheet
Total assets
$1.45B
Total liabilities
$592.43M
Debt
$114.14M
Equity
$858.93M
Working capital
$86.07M
Liquidity
Debt to equity
0.13
Current ratio
1.19
Quick ratio
1.1
Net debt/EBITDA
-1.01
Margins
EBITDA margin
22.6%
Gross margin
30.6%
Net margin
16.7%
Operating margin
18.8%
Efficiency
Return on assets
11.9%
Return on equity
20%
Return on invested capital
180.4%
Return on capital employed
18%
Return on sales
18.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MEDP stock price

How has the Medpace Holdings stock price performed over time
Intraday
0.99%
1 week
3.52%
1 month
10.43%
1 year
116.03%
YTD
25.83%
QTD
6.77%

Financial performance

How have Medpace Holdings's revenue and profit performed over time
Revenue
$955.01M
Gross profit
$292.08M
Operating income
$179.14M
Net income
$159.74M
Gross margin
30.6%
Net margin
16.7%
The net income has increased by 45% YoY and by 10% from the previous quarter
The net margin is up by 35% year-on-year and by 6% since the previous quarter
The operating income has increased by 31% year-on-year and by 7% since the previous quarter
The operating margin has grown by 22% YoY and by 4.4% from the previous quarter

Growth

What is Medpace Holdings's growth rate over time

Valuation

What is Medpace Holdings stock price valuation
P/E
39.1
P/B
7.29
P/S
6.56
EV/EBIT
33.67
EV/EBITDA
28.2
EV/Sales
6.37
The EPS is up by 47% YoY and by 10% QoQ
The P/E is 20% lower than the 5-year quarterly average of 49.0 but 16% higher than the last 4 quarters average of 33.6
MEDP's price to book (P/B) is 108% higher than its 5-year quarterly average of 3.5 and 30% higher than its last 4 quarters average of 5.6
Medpace Holdings's equity has increased by 20% YoY and by 7% from the previous quarter
MEDP's price to sales (P/S) is 93% more than its 5-year quarterly average of 3.4 and 34% more than its last 4 quarters average of 4.9
MEDP's revenue is up by 7% year-on-year and by 3.1% since the previous quarter

Efficiency

How efficient is Medpace Holdings business performance
MEDP's ROIC has shrunk by 92% YoY and by 13% QoQ
The company's return on equity rose by 27% YoY and by 5% QoQ
The ROS is up by 23% YoY and by 3.8% QoQ
Medpace Holdings's return on assets has increased by 18% YoY and by 3.5% QoQ

Dividends

What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MEDP.

Financial health

How did Medpace Holdings financials performed over time
The company's total assets is 145% higher than its total liabilities
The total liabilities has grown by 41% YoY
Medpace Holdings's quick ratio has increased by 38% YoY and by 10% QoQ
The debt is 87% smaller than the equity
The debt has soared by 122% year-on-year
MEDP's debt to equity has surged by 86% year-on-year but it is down by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.